These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27818949)

  • 61. Radionuclide and Fluorescence Imaging of Clear Cell Renal Cell Carcinoma Using Dual Labeled Anti-Carbonic Anhydrase IX Antibody G250.
    Muselaers CH; Rijpkema M; Bos DL; Langenhuijsen JF; Oyen WJ; Mulders PF; Oosterwijk E; Boerman OC
    J Urol; 2015 Aug; 194(2):532-8. PubMed ID: 25686542
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature.
    Cai W; Chen K; Li ZB; Gambhir SS; Chen X
    J Nucl Med; 2007 Nov; 48(11):1862-70. PubMed ID: 17942800
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multifunctional self-assembled peptide nanoparticles for multimodal imaging-guided enhanced theranostic applications against glioblastoma multiforme.
    Rizvi SFA; Ali A; Ahmad M; Mu S; Zhang H
    Nanoscale Adv; 2021 Oct; 3(20):5959-5967. PubMed ID: 36132681
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.
    Zhang Y; Hong H; Nayak TR; Valdovinos HF; Myklejord DV; Theuer CP; Barnhart TE; Cai W
    Angiogenesis; 2013 Jul; 16(3):663-74. PubMed ID: 23471463
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates.
    Patil V; Gada K; Panwar R; Varvarigou A; Majewski S; Weisenberger A; Ferris C; Tekabe Y; Khaw BA
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):824-39. PubMed ID: 22302089
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multimodality imaging using SPECT/CT and MRI and ligand functionalized 99mTc-labeled magnetic microbubbles.
    Barrefelt AA; Brismar TB; Egri G; Aspelin P; Olsson A; Oddo L; Margheritelli S; Caidahl K; Paradossi G; Dähne L; Axelsson R; Hassan M
    EJNMMI Res; 2013 Feb; 3(1):12. PubMed ID: 23442550
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Proof of Concept Study for Increasing Tenascin-C-Targeted Drug Delivery to Tumors Previously Subjected to Therapy: X-Irradiation Increases Tumor Uptake.
    Sugyo A; Tsuji AB; Sudo H; Takano K; Kusakabe M; Higashi T
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291427
    [TBL] [Abstract][Full Text] [Related]  

  • 69. First Evaluation of Radioiodinated Flavonoids as Necrosis-Avid Agents and Application in Early Assessment of Tumor Necrosis.
    Liang J; Sun Z; Zhang D; Jin Q; Cai L; Ma L; Liu W; Ni Y; Zhang J; Yin Z
    Mol Pharm; 2018 Jan; 15(1):207-215. PubMed ID: 29226682
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor-targeted small molecule for dual-modal imaging-guided phototherapy upon near-infrared excitation.
    Meng X; Li W; Sun Z; Zhang J; Zhou L; Deng G; Gong P; Cai L
    J Mater Chem B; 2017 Dec; 5(47):9405-9411. PubMed ID: 32264543
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging.
    Key J; Dhawan D; Cooper CL; Knapp DW; Kim K; Kwon IC; Choi K; Park K; Decuzzi P; Leary JF
    Int J Nanomedicine; 2016; 11():4141-55. PubMed ID: 27621615
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.
    Houghton JL; Zeglis BM; Abdel-Atti D; Aggeler R; Sawada R; Agnew BJ; Scholz WW; Lewis JS
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15850-5. PubMed ID: 26668398
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice.
    Ren Y; Fleischmann D; Foygel K; Molvin L; Lutz AM; Koong AC; Jeffrey RB; Tian L; Willmann JK
    Invest Radiol; 2012 Jan; 47(1):25-32. PubMed ID: 22178893
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
    Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer.
    Adumeau P; Carnazza KE; Brand C; Carlin SD; Reiner T; Agnew BJ; Lewis JS; Zeglis BM
    Theranostics; 2016; 6(12):2267-2277. PubMed ID: 27924162
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
    McLarty K; Cornelissen B; Cai Z; Scollard DA; Costantini DL; Done SJ; Reilly RM
    J Nucl Med; 2009 Aug; 50(8):1340-8. PubMed ID: 19617342
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells.
    van Lith SAM; Huizing FJ; Franssen GM; Hoeben BAW; Lok J; Doulkeridou S; Boerman OC; Gotthardt M; van Bergen En Henegouwen PMP; Bussink J; Heskamp S
    Mol Pharm; 2022 Oct; 19(10):3511-3520. PubMed ID: 35044182
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Receptor-binding, biodistribution, dosimetry, and micro-SPECT/CT imaging of 111In-[DTPA(1), Lys(3), Tyr(4)]-bombesin analog in human prostate tumor-bearing mice.
    Ho CL; Chen LC; Lee WC; Chiu SP; Hsu WC; Wu YH; Yeh CH; Stabin MG; Jan ML; Lin WJ; Lee TW; Chang CH
    Cancer Biother Radiopharm; 2009 Aug; 24(4):435-43. PubMed ID: 19694578
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.